SCHEMBL16640755

SCHEMBL16640755

Oc1c(Cc2ccccc2)c(CF)nc2ccc(Br)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
DPP4 P27487 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
VKORC1 Q9BQB6 1/20 0.38
ALKBH3 Q96Q83 1/20 0.37
KMT2A Q03164 3/20 0.37
ATM Q13315 2/20 0.37
PIK3CD O00329 1/20 0.36
PIK3R1 P27986 1/20 0.36
HIF1A Q16665 1/20 0.36
PTGFR P43088 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
RXFP1 Q9HBX9 2/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16633125 0.81 NT5E (0.42) LMNAHTTSMN1; SMN2CCNCCDK8
SCHEMBL16460893 0.76 RORC (0.41) LMNAHTTSMN1; SMN2L3MBTL1VKORC1
SCHEMBL16632633 0.71 RORC (0.42)
SCHEMBL16460911 0.70 CYP1A2 (0.45) LMNAHTTSMN1; SMN2L3MBTL1VKORC1
SCHEMBL12749514 0.70 CYP1A2 (0.54) LMNAHTTSMN1; SMN2CCNCCDK8
SCHEMBL16632923 0.69 VKORC1 (0.42) LMNASMN1; SMN2VKORC1KDM4EALDH1A1
SCHEMBL12749451 0.68 AURKA (0.59) PTGFRRXFP1CRHBPCRHR2MAPT
SCHEMBL6379346 0.68 BCL2 (0.40) HTTKDM4EALDH1A1
SCHEMBL18102298 0.68 DPP4 (0.51) HTTSMN1; SMN2DPP4L3MBTL1KMT2A
SCHEMBL16632999 0.68 CYP1A2 (0.48) LMNAHTTSMN1; SMN2CCNCCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150105366-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt JANSSEN PHARMACEUTICA NV (BE) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105366-A1 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt RORC, RORA, RORB LMNA 3340/4885HTT 2376/4885SMN1; SMN2 4233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.